Riskpilot← Back to searchSign inGet full accessHALLINGDALSAPOTEKENE AS
ASActiveOrg 915429793Torsetvegen 575A, 3560 HemsedalRetail sale of pharmaceutical products · NACE 4773Est. 201519 employeeswww.dittapotek.no
Revenue 2024
NOK 38,7M
+12% vs 2023
EBITDA margin
6.4%
-7% vs 2023
Equity ratio
5.9%
Financial strength
Net profit 2024
NOK 1,8M
-7% vs 2023
| Revenue | NOK 38,7M | +12% |
| EBITDA | NOK 2,5M | -7% |
| Net profit | NOK 1,8M | -7% |
| Total assets | NOK 9,9M | -9% |
| Equity | NOK 582K | -16% |
| Employees | 19 | — |
Legal name
HALLINGDALSAPOTEKENE AS
Org number
915429793
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
22. mai 2015
Share capital
NOK 550 000
Employees
19 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskapets firma tegnes av daglig leder og ett styremedlem i fellesskap eller styrets leder og ett styremedlem i fellesskap.
Company purpose
Formålet til selskapet er å drive apotek, salg av apotekvarer og tilhørende farmasøytiske tjenester og oppgaver.
Address
Torsetvegen 575A, 3560 Hemsedal
Phone
+4732060001
Email
hemsedal@dittapotek.no
Website
www.dittapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 860 | 8 836 | 10 227 | 10 997 | 12 615 | 14 399 | 22 898 | 31 879 | 34 451 | 38 732 |
| Staff expenses | −285 | −1 848 | −2 016 | −2 321 | −2 555 | −2 520 | −4 061 | −5 390 | −5 964 | −6 931 |
| EBITDA | −269 | −3 | 275 | 299 | 288 | 965 | 1 563 | 2 046 | 2 639 | 2 461 |
| Depreciation & amort. | −19 | −115 | −116 | −117 | −117 | −108 | −88 | −121 | −121 | −121 |
| EBIT | −287 | −118 | 159 | 182 | 171 | 856 | 1 475 | 1 925 | 2 518 | 2 340 |
| Net financials | −14 | −54 | −50 | −41 | −38 | −24 | −33 | −41 | −45 | −41 |
| Profit before tax | −302 | −171 | 109 | 141 | 133 | 832 | 1 443 | 1 885 | 2 474 | 2 299 |
| Tax | −0 | −0 | −0 | −0 | −0 | 166 | 317 | 415 | 545 | 506 |
| Net profit | −302 | −171 | 109 | 141 | 133 | 667 | 1 125 | 1 470 | 1 929 | 1 792 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 076 | 2 594 | 2 701 | 3 454 | 3 416 | 4 298 | 8 627 | 7 809 | 10 907 | 9 905 |
| Equity | 237 | 66 | 175 | 316 | 449 | 1 116 | 691 | 761 | 690 | 582 |
| Long-term debt | 0 | 1 183 | 983 | 783 | 583 | 402 | 888 | 692 | 491 | 287 |
| Short-term debt | 2 455 | 1 345 | 1 542 | 2 355 | 2 384 | 2 780 | 7 048 | 6 355 | 9 726 | 9 035 |
| Total debt | 3 839 | 2 528 | 2 525 | 3 138 | 2 967 | 3 182 | 7 936 | 7 048 | 10 217 | 9 322 |
EBITDA margin
6.4%
This company
15.8%
Market median
-59% vs market
20152024
Equity ratio
5.9%
This company
38.2%
Market median
-85% vs market
20152024
Return on equity
307.7%
This company
18.4%
Market median
+1572% vs market
20152024
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
20152024
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20152024
Debt / equity
16.00×
This company
0.62×
Market median
-2481% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CV Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HALLINGDALSAPOTEKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Vestgøte Sæther | Chief Executive Officer | 0 companies |
| Jonas Bakko Enoksen | Board of Directors | 0 companies |
| Sveinung Halbjørhus | Chairman | 0 companies |
| Torill Bakko | Board of Directors | 0 companies |
| Torill Bakko Enoksen | Board of Directors | 0 companies |
| Jonas Enoksen | Board of Directors | 0 companies |